124041-02-7

Usage

InChI:InChI=1/C10H6Cl2N2O/c11-7-1-3-8(4-2-7)15-10-5-9(12)13-6-14-10/h1-6H

Upstream product

• 1193-21-1 4,6-dichloropyrimidine 
• 106-48-9 4-chloro-phenol 

Downstream Products

• 95546-85-3 4,6-bis(ethoxycarbonylmethylthio)pyrimidine 
• 124066-44-0 ethyl <6-(4-chlorophenoxy)-4-pyrimidinylthio>acetate 
• 607723-68-2 2-{[6-(4-chlorophenoxy)pyrimidin-4-yl]methylamino}ethanol 
• 1392101-37-9 7-(4-chlorophenoxy)-[1,2,4]triazolo[4,3-c]pyrimidine 
• 1417456-80-4 7-(4-chlorophenoxy)-[1,2,4]triazolo[4,3-c]pyrimidine-3(2H)-thione 
• 1417456-81-5 7-(4-chlorophenoxy)-[1,2,4]triazolo[4,3-c]pyrimidin-3-amine 
• 1417456-83-7 7-(4-chlorophenoxy)-tetrazolo[1,5-f]pyrimidine 
• 1417456-84-8 8-(4-chlorophenoxy)-3-methyl-4H-pyrimido[6,1-c][1,2,4]triazin-4-one 
• 607723-86-4 4-({2-[6-(4-chlorophenoxy)pyrimidin-4-yl]methylamino}ethoxy)benzaldehyde 

Relevant academic research and scientific papers

Design, synthesis and anticonvulsant activity evaluation of 7-substituted -[1,2,4]-triazolo[4,3-f]pyrimidine derivatives

In this study, a novel series of 7-substituted-[1,2,4]triazolo[4,3-f] pyrimidine derivatives was synthesized as potential anticonvulsant agents. Their anticonvulsant activities were evaluated by the maximal electroshock (MES) test, and their neurotoxiciti

MODULATORS FOR AMYLOID BETA

The invention relates to compounds of formula wherein the substituents are as described in claim 1. Compounds of formula I are modulators for amyloid beta and thus, they may be useful for the treatment or prevention of a disease associated with the deposi

Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione

We previously reported the synthesis and biological activity of novel substituted pyridines and purines having thiazolidinedione with hypoglycemic and hypolipidemic activities. We now report the synthesis and antidiabetic activity of novel substituted pyr